Is Nektar Therapeutics (NKTR) a Buy, Sell, or Hold?
Nektar Therapeutics
NASDAQ:NKTR
$65.77 USD
-$1.4 (-2.08%)
- Volume
- 26.15K
- Average Volume
- 1.17M
- Market Capitalization
- $1.29B
- P/E Ratio
- -7.81
- Dividend Yield
- 0.00%
- Price Target
- $151.00
- Year High
- $109.00
- Year Low
- $21.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.21
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
18
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
34
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 65504
NKTR Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
NKTR Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Zalevsky Jonathan | officer: Chief R&D Officer | 2026-06-30 | S-Sale | 70 | 2026-07-02 |
| ROBIN HOWARD W | director, officer: President & CEO | 2026-06-16 | S-Sale | 59.97 | 2026-06-18 |
| ROBIN HOWARD W | director, officer: President & CEO | 2026-06-16 | S-Sale | 60.71 | 2026-06-18 |
| ROBIN HOWARD W | director, officer: President & CEO | 2026-06-17 | S-Sale | 60.81 | 2026-06-18 |
| ROBIN HOWARD W | director, officer: President & CEO | 2026-06-17 | S-Sale | 61.65 | 2026-06-18 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2026-06-15 | S-Sale | 60.71 | 2026-06-17 |
| Rubinstein Linda M | 2026-05-15 | 0 | 2026-05-26 | ||
| Zalevsky Jonathan | officer: Chief R&D Officer | 2026-05-19 | S-Sale | 65.51 | 2026-05-21 |
| ROBIN HOWARD W | director, officer: President & CEO | 2026-05-19 | S-Sale | 65.51 | 2026-05-21 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2026-02-18 | S-Sale | 73 | 2026-02-20 |
| ROBIN HOWARD W | director, officer: President & CEO | 2026-02-18 | S-Sale | 73 | 2026-02-20 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2026-01-20 | S-Sale | 35.67 | 2026-01-22 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-12-22 | A-Award | 0 | 2025-12-23 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-12-22 | A-Award | 43.48 | 2025-12-23 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-12-22 | A-Award | 43.48 | 2025-12-23 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-12-22 | A-Award | 0 | 2025-12-23 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-11-21 | A-Award | 0 | 2025-11-25 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-11-25 | S-Sale | 54.28 | 2025-11-25 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-11-21 | A-Award | 281.25 | 2025-11-25 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2025-11-21 | A-Award | 0 | 2025-11-25 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2025-11-25 | S-Sale | 54.28 | 2025-11-25 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2025-11-21 | A-Award | 281.25 | 2025-11-25 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-11-21 | A-Award | 0 | 2025-11-25 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-11-25 | S-Sale | 54.28 | 2025-11-25 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-11-21 | A-Award | 281.25 | 2025-11-25 |
| WHITFIELD ROY A | director | 2025-09-30 | A-Award | 56.9 | 2025-10-01 |
| GREER R SCOTT | director | 2025-09-30 | A-Award | 56.9 | 2025-10-01 |
| CHESS ROBERT | director | 2025-09-30 | A-Award | 56.9 | 2025-10-01 |
| Brainard Diana | director | 2025-09-30 | A-Award | 56.9 | 2025-10-01 |
| Ajer Jeffrey Robert | director | 2025-09-30 | A-Award | 56.9 | 2025-10-01 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-09-09 | S-Sale | 45.16 | 2025-09-11 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-09-09 | S-Sale | 46.41 | 2025-09-11 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-09-09 | S-Sale | 47.49 | 2025-09-11 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-09-09 | S-Sale | 48.18 | 2025-09-11 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-09-04 | S-Sale | 32.43 | 2025-09-08 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-09-04 | S-Sale | 33.6 | 2025-09-08 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-09-04 | S-Sale | 34.41 | 2025-09-08 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-09-04 | S-Sale | 35.69 | 2025-09-08 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-09-04 | S-Sale | 32.37 | 2025-09-08 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-09-04 | S-Sale | 33.54 | 2025-09-08 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-09-04 | S-Sale | 34.4 | 2025-09-08 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-09-04 | S-Sale | 35.8 | 2025-09-08 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-09-05 | S-Sale | 37.87 | 2025-09-08 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-09-05 | S-Sale | 38.82 | 2025-09-08 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-09-05 | S-Sale | 39.89 | 2025-09-08 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-09-02 | S-Sale | 30.1 | 2025-09-04 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-09-02 | S-Sale | 30.16 | 2025-09-04 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-08-19 | S-Sale | 26.59 | 2025-08-21 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-08-19 | A-Award | 0.5 | 2025-08-21 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2025-08-19 | A-Award | 0.5 | 2025-08-21 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2025-08-19 | S-Sale | 26.59 | 2025-08-21 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-08-19 | A-Award | 0.5 | 2025-08-21 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-08-19 | S-Sale | 26.59 | 2025-08-21 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-05-19 | S-Sale | 0.67 | 2025-05-21 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2025-05-19 | S-Sale | 0.67 | 2025-05-21 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-05-19 | S-Sale | 0.67 | 2025-05-21 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2025-02-19 | S-Sale | 1.01 | 2025-02-21 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2025-02-19 | S-Sale | 1.01 | 2025-02-21 |
| ROBIN HOWARD W | director, officer: President & CEO | 2025-02-19 | S-Sale | 1.01 | 2025-02-21 |
| WHITFIELD ROY A | director | 2024-09-18 | A-Award | 1.26 | 2025-01-17 |
| GREER R SCOTT | director | 2024-09-18 | A-Award | 1.26 | 2025-01-17 |
| CHESS ROBERT | director | 2024-09-18 | A-Award | 1.26 | 2025-01-17 |
| Brainard Diana | director | 2024-09-18 | A-Award | 1.26 | 2025-01-17 |
| Ajer Jeffrey Robert | director | 2024-09-18 | A-Award | 1.26 | 2025-01-17 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2024-12-23 | S-Sale | 0.9 | 2024-12-26 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2024-12-24 | S-Sale | 0.89 | 2024-12-26 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2024-12-19 | S-Sale | 0.94 | 2024-12-20 |
| ROBIN HOWARD W | director, officer: President & CEO | 2024-12-17 | S-Sale | 1.01 | 2024-12-19 |
| ROBIN HOWARD W | director, officer: President & CEO | 2024-12-18 | S-Sale | 0.99 | 2024-12-19 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2024-12-13 | A-Award | 0 | 2024-12-17 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2024-12-13 | A-Award | 1.01 | 2024-12-17 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2024-12-13 | A-Award | 4.91 | 2024-12-17 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2024-12-13 | A-Award | 0 | 2024-12-17 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2024-12-13 | A-Award | 4.91 | 2024-12-17 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2024-12-13 | A-Award | 1.01 | 2024-12-17 |
| ROBIN HOWARD W | director, officer: President & CEO | 2024-12-13 | A-Award | 1.01 | 2024-12-17 |
| ROBIN HOWARD W | director, officer: President & CEO | 2024-12-13 | A-Award | 0 | 2024-12-17 |
| ROBIN HOWARD W | director, officer: President & CEO | 2024-12-13 | A-Award | 4.91 | 2024-12-17 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2024-11-19 | S-Sale | 1.01 | 2024-11-20 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2024-11-19 | S-Sale | 1.01 | 2024-11-20 |
| ROBIN HOWARD W | director, officer: President & CEO | 2024-11-19 | S-Sale | 1.01 | 2024-11-20 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2024-08-19 | S-Sale | 1.28 | 2024-08-20 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2024-08-19 | S-Sale | 1.28 | 2024-08-20 |
| ROBIN HOWARD W | director, officer: President & CEO | 2024-08-19 | S-Sale | 1.28 | 2024-08-20 |
| CHESS ROBERT | director | 2024-06-14 | S-Sale | 1.2 | 2024-06-14 |
| ROBIN HOWARD W | director, officer: President & CEO | 2024-05-17 | S-Sale | 1.75 | 2024-05-20 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2024-05-17 | S-Sale | 1.75 | 2024-05-20 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2024-05-17 | S-Sale | 1.75 | 2024-05-20 |
| Deep Track Capital, LP | 10 percent owner | 2024-05-10 | S-Sale | 1.7791 | 2024-05-13 |
| Deep Track Capital, LP | 10 percent owner | 2024-03-05 | 0 | 2024-03-14 | |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2024-02-20 | S-Sale | 0.68 | 2024-02-22 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2024-02-20 | S-Sale | 0.68 | 2024-02-22 |
| ROBIN HOWARD W | director, officer: President & CEO | 2024-02-20 | S-Sale | 0.68 | 2024-02-22 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2023-12-13 | A-Award | 0.5 | 2023-12-15 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2023-12-13 | A-Award | 0.5 | 2023-12-15 |
| ROBIN HOWARD W | director, officer: President & CEO | 2023-12-13 | A-Award | 0.5 | 2023-12-15 |
| Zalevsky Jonathan | officer: Chief R&D Officer | 2023-11-17 | S-Sale | 0.49 | 2023-11-20 |
| Wilson Mark Andrew | officer: Chief Legal Officer | 2023-11-17 | S-Sale | 0.49 | 2023-11-20 |
| ROBIN HOWARD W | director, officer: President & CEO | 2023-11-17 | S-Sale | 0.49 | 2023-11-20 |
| GREER R SCOTT | director | 2023-09-19 | A-Award | 0.68 | 2023-09-21 |